Draft genome sequence of Enterococcus faecalis PC1.1, a candidate probiotic strain isolated from human feces

Genome Announcements

Volumn 1, Issue 1, 2013, Pages

  Cuív, Páraic Ó ^a   Klaassens, Eline S ^a,d   Smith, Wendy J ^a   Mondot, Stanislas ^a   Durkin, A Scott ^b   Harkins, Derek M ^b   Foster, Les ^b   McCorrison, Jamison ^b   Torralba, Manolito ^b   Nelson, Karen E ^b   Morrison, Mark ^a,c  

^a CSIRO   (Australia)

^b J CRAIG VENTER INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84995900596     PISSN: None     EISSN: 21698287     Source Type: Journal    
DOI: 10.1128/genomeA.00160-12     Document Type: Article

References (16)

1. Hopkins MJ, Macfarlane GT, Furrie E, Fite A, Macfarlane S. 2005. Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses. FEMS Microbiol. Ecol. 54:77-85.
2. Kirtzalidou EI, Mitsou EK, Pramateftaki P, Kyriacou A. 2012. Screening fecal enterococci from Greek healthy infants for susceptibility to antimicrobial agents. Microb. Drug Resist. 18:578-85.
3. Noble CJ. 1978. Carriage of group D streptococci in the human bowel. J. Clin. Pathol. 31:1182-1186.
4. Cebrián R, Baños A, Valdivia E, Pérez-Pulido R, Martínez-Bueno M, Maqueda M. 2012. Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain. Food Microbiol. 30:59-67.
5. Soerjadi AS, Lloyd AB, Cumming RB. 1978. Streptococcus faecalis, a bacterial isolate which protects young chickens from enteric invasion by salmonellae. Aust. Vet. J. 54:549-550.
6. Are A, Aronsson L, Wang S, Greicius G, Lee YK, Gustafsson JA, Pettersson S, Arulampalam V. 2008. Enterococcus faecalis from newborn babies regulate endogenous PPARγ activity and IL-10 levels in colonic epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 105:1943-1948.
7. Wang S, Ng LH, Chow WL, Lee YK. 2008. Infant intestinal Enterococcus faecalis down-regulates inflammatory responses in human intestinal cell lines. World J. Gastroenterol. 14:1067-1076.
8. Chen CC, Kong MS, Lai MW, Chao HC, Chang KW, Chen SY, Huang YC, Chiu CH, Li WC, Lin PY, Chen CJ, Li TY. 2010. Probiotics have clinical, microbiologic, and immunologic efficacy in acute infectious diarrhea. Pediatr. Infect. Dis. J. 29:135-138
9. Enck P, Zimmermann K, Menke G, Müller-Lissner S, Martens U, Klosterhalfen S. 2008. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome-a randomized controlled trial with primary care physicians. Neurogastroenterol. Motil. 20:1103-1109.
10. Tsuda Y, Yoshimatsu Y, Aoki H, Nakamura K, Irie M, Fukuda K, Hosoe N, Takada N, Shirai K, Suzuki Y. 2007. Clinical effectiveness of probiotics therapy (bio-three) in patients with ulcerative colitis refractory to conventional therapy. Scand. J. Gastroenterol. 42:1306-131.
11. Steck N, Hoffmann M, Sava IG, Kim SC, Hahne H, Tonkonogy SL, Mair K, Krueger D, Pruteanu M, Shanahan F, Vogelmann R, Schemann M, Kuster B, Sartor RB, Haller D. 2011. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 141:959-971.
12. Balish E, Warner T. 2002. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am. J. Pathol. 160: 2253-2257.
13. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB. 2005. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128:891-906.
14. Huycke MM, Abrams V, Moore DR. 2002. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23:529-536.
15. Wang X, Huycke MM. 2007. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132:551-561
16. Gerding DN. 2012. Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines. Discov. Med. 13:75-83.